The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Sprt Regulatory News (SIS)

Share Price Information for Science Sprt (SIS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.75
Bid: 15.50
Ask: 16.00
Change: 0.00 (0.00%)
Spread: 0.50 (3.226%)
Open: 15.75
High: 15.75
Low: 15.75
Prev. Close: 15.75
SIS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of Equity

21 Mar 2019 07:00

RNS Number : 5106T
Science in Sport PLC
21 March 2019
 

21 March 2019

 

SCIENCE IN SPORT PLC

 

("SiS" or the "Company")

 

Issue of equity

 

Science in Sport plc (AIM: SIS), a leading premium performance nutrition company that develops, manufactures and markets performance nutrition products for elite athletes, sports and gym lifestyle enthusiasts, announces that it has applied for 240,385 new ordinary shares of 10 pence each ("New Ordinary Shares") to be admitted to trading on AIM ("Admission").

 

The New Ordinary Shares are being issued as consideration related to sponsorship services. It is expected that dealings in the New Ordinary Shares will commence at 8.00 a.m. on 27 March 2019.

 

Following Admission, the Company will have 122,819,029 ordinary shares of 10 pence each ("Ordinary Shares") outstanding, none of which are held in treasury. The figure of 122,819,029 Ordinary Shares may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

 

For further information:

 

Science in Sport plc

 

+44 (0) 20 7400 3700

Stephen Moon, CEO

Elizabeth Lake, FD

Liberum Capital Ltd

Nominated adviser and broker

+44 (0) 20 3100 2000

Clayton Bush

Chris Clarke

James Greenwood

 

Instinctif Partners

Financial PR

Matthew Smallwood

Tom Berger

 

 

+44 (0) 20 7457 2020

About Science in Sport plc

 

Science in Sport plc is a leading sports nutrition company that develops, manufactures and markets sports nutrition products for professional athletes and sports enthusiasts. SiS is a strong brand in the elite athlete community - in the 2016 Rio Olympics, 34 medal-winning athletes or teams used SiS products (compared with 24 in 2012).

 

The SiS core product ranges include: SiS GO, comprising energy powders, isotonic gels, energy bars and shots; SiS REGO, including protein-based recovery powders; SiS Protein, products specifically designed to contribute to athletes' lean muscle mass growth and maintenance; SiS Supplements, comprising BCAA Perform, Creatine, Beta Alanine and L Glutamine; SiS Athlete Health, vitamins and supplements range designed to support and maintain immune function, digestive health and bone health. SiS products are sold in a range of retail channels, including specialist sport retailers, major grocers, high street retailers and e-commerce websites.

 

SiS is currently the official sports nutrition supplier to professional cycling organisations Team SKY, British Cycling, Cycling Australia and USA Cycling. SiS is also a partner to British Triathlon & Rock n Roll Marathon Series. Along with supplying over 80 professional English & Scottish League football teams, SiS is Sports Nutrition Partner to the world's most popular football club, Manchester United FC. In addition, Olympians Sir Chris Hoy MBE, Mark Cavendish MBE and Adam Peaty MBE are Brand Ambassadors.

 

SiS was founded in 1992 and is headquartered in Hatton Garden, London. Its manufacturing facility is in Nelson, Lancashire.

 

SiS shares are traded on the AIM market of the London Stock Exchange under the ticker symbol SIS.

 

About PhD

PhD is a UK-headquartered premium protein brand. Since being founded by Jason Rickaby and Mark Bowering in 2005, PhD has developed into one of the UK's leading protein brands with a reputation for high quality and innovative products aimed at sports enthusiasts and gym lifestyle consumers.

 

It has c.24 employees and an experienced management team that has a track record of delivering consistent revenue growth and profitability. For the year ended August 2018, PhD reported revenues of £20.8 million and adjusted EBITDA of £2.8 million.

 

For further information, please visit www.scienceinsport.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEKBLFLKXFZBBL
Date   Source Headline
18th Jan 20184:41 pmRNSIssue of Equity
18th Jan 20187:00 amRNSSiS becomes Official Partner of Manchester United
17th Jan 20183:44 pmRNSHolding(s) in Company
16th Jan 20187:00 amRNSPre-Close Trading Update
6th Dec 20174:47 pmRNSHolding(s) in Company
6th Dec 201710:29 amRNSHolding(s) in Company
6th Dec 201710:27 amRNSHolding(s) in Company
6th Dec 201710:20 amRNSHolding(s) in Company
5th Dec 20177:00 amRNSHolding(s) in Company
4th Dec 20171:22 pmRNSDirector/PDMR Shareholding
1st Dec 201712:44 pmRNSResults of General Meeting and Open Offer
14th Nov 20177:00 amRNSFirm Placing and Open Offer
27th Oct 20177:00 amRNSSiS announces partnership with Rock 'n' Roll
27th Oct 20177:00 amRNSSiS announces three-year deal with USA Triathlon
20th Sep 20179:06 amRNSHalf-year Report - Replacement
20th Sep 20177:00 amRNSHalf-year Report
12th Sep 20172:43 pmRNSHolding(s) in Company
11th Sep 20177:00 amRNSTHREE MORE YEARS FOR SiS AND TEAM SKY
4th Aug 20177:00 amRNSSIS to fuel leading British football clubs
3rd Aug 20177:00 amRNSNotice of Results
20th Jul 20177:00 amRNSHalf Year Trading Update
26th Jun 20174:30 pmEQSCavendish Asset Management: Paul Mumford named Small Cap Awards' Fund Manager of the Year
26th Jun 201712:29 pmRNSDirector/PDMR Shareholding
21st Jun 201712:44 pmRNSResult of AGM
20th Jun 20178:00 amRNSPDMR Dealing
15th Jun 20177:00 amRNSSIS to fuel British Triathlon
30th May 20177:00 amRNSSIS granted patent for novel WHEY20
19th May 20175:17 pmRNSPosting of Annual Report
18th May 20177:00 amRNSSIS to Fuel Cycling Australia To Tokyo 2020
12th May 20179:00 amRNSHolding(s) in Company
3rd May 20179:23 amRNSHolding(s) in Company
23rd Mar 20171:00 pmRNSPDMR Dealings and Issue of Equity
23rd Mar 20177:00 amRNSFinal Results
2nd Mar 20179:15 amRNSTotal Voting Rights
19th Jan 20178:44 amRNSHolding(s) in Company
17th Jan 20177:00 amRNSSIS Extends World Class Banned Substance Testing
10th Jan 20177:00 amRNSSIS To Fuel British Cycling To Tokyo 2020
9th Jan 20175:24 pmRNSIssue of Equity
5th Jan 20177:00 amRNSPre-Close Trading Update
29th Nov 20167:00 amRNSSiS receives award from Investors in People
17th Nov 20167:00 amRNSDirector/PDMR Shareholding
16th Nov 20167:00 amRNSDirector/PDMR Shareholding
27th Oct 20167:00 amRNSDirector/PDMR Shareholding
18th Oct 20167:00 amRNSAppointment of US Country Manager
26th Sep 20164:09 pmRNSNew Long Term Incentive Plan
22nd Sep 20167:00 amRNSHalf Yearly Report
21st Sep 20162:45 pmRNSAppointment of Non-Executive Director
1st Sep 20167:00 amRNSTwo New Senior Appointments
30th Aug 20167:00 amRNSOfficial Sports Nutrition Partner to Liverpool FC
25th Aug 20162:04 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.